Status:
COMPLETED
Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics
Lead Sponsor:
Rhode Island Hospital
Conditions:
At-risk Drinking
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to test an intervention to reduce at-risk drinking among Type 2 diabetic patients. At-risk drinking is associated with inferior diabetes treatment adherence and control. The inv...
Detailed Description
At-risk drinking is common among diabetic patients and is associated with inferior diabetes treatment adherence and outcomes. While methods for reducing alcohol use in this population have been largel...
Eligibility Criteria
Inclusion
- 18 years or older,
- have Type 2 diabetes,
- report at-risk drinking in past month,
- report poor diabetes treatment adherence.
Exclusion
- current alcohol dependence or current psychoactive substance abuse or dependence (excluding nicotine),
- currently psychotic,
- unable to provide the name and contact information for a significant other to corroborate self-report,
- unable to provide the name and contact information for two people who could serve as locators, do not have access to a telephone.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT00950040
Start Date
July 1 2009
End Date
March 1 2017
Last Update
April 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02903